Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografiska uppgifter
Huvudupphovsman: Akter, Honufa
Övriga upphovsmän: Sharmin, Sabrina
Materialtyp: Lärdomsprov
Språk:English
Publicerad: Brac University 2024
Ämnen:
Länkar:http://hdl.handle.net/10361/23619
id 10361-23619
record_format dspace
spelling 10361-236192024-06-27T21:01:42Z Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review Akter, Honufa Sharmin, Sabrina School of Pharmacy, Brac University Doxorubicin Breast cancer Liposome Liposomal doxorubicin Cardiotoxicity Metastasis Breast cancer--Treatment. This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. Cataloged from the PDF version of the thesis. Includes bibliographical references (pages 35-48). Breast cancer continues to be one of the most common reasons for hospitalization and mortality each year. As time goes on, novel anticancer drug formulations are being released on the market, raising the concern of medical professionals due to their superiority, toxicology, and cost-effectiveness compared to the traditional formulation of the same drugs. Doxorubicin is an effective cancer drug that comes in three forms: pegylated liposomal, nonpegylated liposomal, and conventional non-liposomal. Although it is more expensive, liposomal doxorubicin has been shown to have a more favorable toxicological profile than conventional. The cost-effectiveness of liposomal doxorubicin has not been thoroughly investigated due to the small number of research that have been conducted. Apart from that this article highlights the use of traditional doxorubicin has been somewhat restricted due to the adverse effects it can produce, whereas liposomal formulation has favorable safety profile. In the overall treatment of breast cancer, the formation of a liposomal form of doxorubicin, which is less harmful to the heart, better tolerated, and just as effective, expands the therapeutic alternatives available. Honufa Akter B. Pharmacy 2024-06-27T05:39:19Z 2024-06-27T05:39:19Z 2023 2023-07 Thesis ID 19346039 http://hdl.handle.net/10361/23619 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 48 pages application/pdf Brac University
institution Brac University
collection Institutional Repository
language English
topic Doxorubicin
Breast cancer
Liposome
Liposomal doxorubicin
Cardiotoxicity
Metastasis
Breast cancer--Treatment.
spellingShingle Doxorubicin
Breast cancer
Liposome
Liposomal doxorubicin
Cardiotoxicity
Metastasis
Breast cancer--Treatment.
Akter, Honufa
Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
description This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
author2 Sharmin, Sabrina
author_facet Sharmin, Sabrina
Akter, Honufa
format Thesis
author Akter, Honufa
author_sort Akter, Honufa
title Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
title_short Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
title_full Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
title_fullStr Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
title_full_unstemmed Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
title_sort comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
publisher Brac University
publishDate 2024
url http://hdl.handle.net/10361/23619
work_keys_str_mv AT akterhonufa comparisonofconventionaldoxorubicinwithliposomeencapsulateddoxorubicinasatreatmentofbreastcancerareview
_version_ 1814307750369296384